Greenwich Stock Volatility

GLSI -  USA Stock  

USD 8.50  0.55  6.92%

Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of -0.25, which attests that the entity had -0.25% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Greenwich Lifesciences exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Greenwich Lifesciences market risk adjusted performance of (22.71), and Risk Adjusted Performance of (0.32) to validate the risk estimate we provide.
  
Refresh
Greenwich Lifesciences Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Greenwich daily returns, and it is calculated using variance and standard deviation. We also use Greenwich's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Greenwich Lifesciences volatility.

180 Days Market Risk

Not too volatile

Chance of Distress

180 Days Economic Sensitivity

Barely shadows the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Greenwich Lifesciences can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Greenwich Lifesciences at lower prices. For example, an investor can purchase Greenwich stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Greenwich Lifesciences' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Greenwich Lifesciences

0.97ALXOAlx Oncology HoldingsPairCorr
0.96AYLAAyala PharmaceuticalsPairCorr
0.96AQSTAquestive TherapeuticsPairCorr
0.96ALLKAllakosPairCorr
0.95AGENAgenus IncPairCorr
0.94ATNXAthenexPairCorr
0.94AIRSAirsculpt TechnologiesPairCorr

Moving against Greenwich Lifesciences

-0.93ARYXAryx TherapeuticsPairCorr
-0.9VLOValero Energy CorpPairCorr
-0.86ADMSAdamas PharmaceuticalsPairCorr
-0.84ANIXAnixa BiosciencesPairCorr
-0.83ANTHAnthera PharmaceuticalsPairCorr
-0.82GOGLGolden Ocean GpPairCorr
-0.81ASPCDAcerus PharmaceuticalsPairCorr

Greenwich Lifesciences Market Sensitivity And Downside Risk

Greenwich Lifesciences' beta coefficient measures the volatility of Greenwich stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Greenwich stock's returns against your selected market. In other words, Greenwich Lifesciences's beta of 0.0486 provides an investor with an approximation of how much risk Greenwich Lifesciences stock can potentially add to one of your existing portfolios.
Let's try to break down what Greenwich's beta means in this case. As returns on the market increase, Greenwich Lifesciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Greenwich Lifesciences will be expected to be smaller as well.
3 Months Beta |Analyze Greenwich Lifesciences Demand Trend
Check current 90 days Greenwich Lifesciences correlation with market (DOW)

Greenwich Beta

    
  0.0486  
Greenwich standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.67  
It is essential to understand the difference between upside risk (as represented by Greenwich Lifesciences's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Greenwich Lifesciences stock's daily returns or price. Since the actual investment returns on holding a position in Greenwich Lifesciences stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Greenwich Lifesciences.

Greenwich Lifesciences Stock Volatility Analysis

Volatility refers to the frequency at which Greenwich Lifesciences stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Greenwich Lifesciences' price changes. Investors will then calculate the volatility of Greenwich Lifesciences' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Greenwich Lifesciences' volatility:

Historical Volatility

This type of stock volatility measures Greenwich Lifesciences' fluctuations based on previous trends. It's commonly used to predict Greenwich Lifesciences' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Greenwich Lifesciences' current market price. This means that the stock will return to its initially predicted market price.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Greenwich Lifesciences Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
.

Greenwich Lifesciences Projected Return Density Against Market

Given the investment horizon of 90 days Greenwich Lifesciences has a beta of 0.0486 . This usually indicates as returns on the market go up, Greenwich Lifesciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Greenwich Lifesciences will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Greenwich Lifesciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Greenwich Lifesciences stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Greenwich stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Greenwich Lifesciences is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
Greenwich Lifesciences' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how Greenwich Lifesciences stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Greenwich Lifesciences Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Greenwich Lifesciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Greenwich Lifesciences stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Greenwich stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Given the investment horizon of 90 days the coefficient of variation of Greenwich Lifesciences is -402.59. The daily returns are distributed with a variance of 21.8 and standard deviation of 4.67. The mean deviation of Greenwich Lifesciences is currently at 3.7. For similar time horizon, the selected benchmark (DOW) has volatility of 1.37
α
Alpha over DOW
-1.1
β
Beta against DOW0.0486
σ
Overall volatility
4.67
Ir
Information ratio -0.24

Greenwich Lifesciences Stock Return Volatility

Greenwich Lifesciences historical daily return volatility represents how much Greenwich Lifesciences stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company inherits 4.6688% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 1.3427% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Greenwich Lifesciences Volatility

Volatility is a rate at which the price of Greenwich Lifesciences or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Greenwich Lifesciences may increase or decrease. In other words, similar to Greenwich's beta indicator, it measures the risk of Greenwich Lifesciences and helps estimate the fluctuations that may happen in a short period of time. So if prices of Greenwich Lifesciences fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market Capitalization319.3 M327.5 M
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Greenwich Lifesciences Investment Opportunity

Greenwich Lifesciences has a volatility of 4.67 and is 3.49 times more volatile than DOW. 40  of all equities and portfolios are less risky than Greenwich Lifesciences. Compared to the overall equity markets, volatility of historical daily returns of Greenwich Lifesciences is lower than 40 () of all global equities and portfolios over the last 90 days. Use Greenwich Lifesciences to enhance returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Greenwich Lifesciences to be traded at $10.63 in 90 days. . Let's try to break down what Greenwich's beta means in this case. As returns on the market increase, Greenwich Lifesciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Greenwich Lifesciences will be expected to be smaller as well.

Significant diversification

The correlation between Greenwich Lifesciences and DJI is Significant diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Greenwich Lifesciences and DJI in the same portfolio, assuming nothing else is changed.

Greenwich Lifesciences Additional Risk Indicators

The analysis of Greenwich Lifesciences' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Greenwich Lifesciences' investment and either accepting that risk or mitigating it. Along with some common measures of Greenwich Lifesciences stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.32)
Market Risk Adjusted Performance(22.71)
Mean Deviation3.71
Coefficient Of Variation(423.08)
Standard Deviation4.63
Variance21.42
Information Ratio(0.24)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Greenwich Lifesciences Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
GM vs. Greenwich Lifesciences
Microsoft Corp vs. Greenwich Lifesciences
Atlassian Cls vs. Greenwich Lifesciences
Citigroup vs. Greenwich Lifesciences
LINGYI ITECH vs. Greenwich Lifesciences
Salesforce vs. Greenwich Lifesciences
Meta Platforms vs. Greenwich Lifesciences
COSCO SHIPPING vs. Greenwich Lifesciences
Vmware vs. Greenwich Lifesciences
Walker Dunlop vs. Greenwich Lifesciences
Visa vs. Greenwich Lifesciences
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Greenwich Lifesciences as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Greenwich Lifesciences' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Greenwich Lifesciences' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Greenwich Lifesciences.
Please check Risk vs Return Analysis. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.